Synthesis and anti-inflammatory evaluation of new 1,3,5-triaryl-4,5-dihydro-1H-pyrazole derivatives possessing an aminosulphonyl pharmacophore

被引：19

作者：

Abdellatif, Khaled R. A. ^{[1
]}

Abdelgawad, Mohamed A. ^{[1
]}

Elshemy, Heba A. H. ^{[1
]}

Alsayed, Shahinda S. R. ^{[1
]}

Kamel, Gehan ^{[2
]}

机构：

[1] Beni Suef Univ, Fac Pharm, Dept Organ Pharmaceut Chem, Bani Suwayf 62514, Egypt

[2] Cairo Univ, Fac Vet, Dept Pharmacol, Cairo, Egypt

来源：

ARCHIVES OF PHARMACAL RESEARCH | 2015年 / 38卷 / 11期

关键词：

Dihydropyrazole; Cyclooxygenase inhibition; Anti-inflammatory; NITRIC-OXIDE RELEASE; CYCLOOXYGENASE COX-2 INHIBITORS; BEARING BENZENE SULFONAMIDE; DONOR ESTER PRODRUGS; BIOLOGICAL EVALUATION; PYRAZOLINE DERIVATIVES; ANTIMICROBIAL ACTIVITIES; CELECOXIB ANALOGS; DESIGN; AGENTS;

D O I：

10.1007/s12272-015-0606-7

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A novel series of 2-pyrazoline derivatives 13a-l was synthesized via aldol condensation of 4-substituted acetophenones with appropriately substituted aldehydes followed by cyclization of the formed chalcones with 4-hydrazinobenzenesulfonamide hydrochloride. The chemical structures of the target pyrazoline derivatives were proved by means of IR, H-1 NMR, C-13 NMR, mass spectroscopy and elemental analyses data. All the synthesized compounds were evaluated for their cyclooxygenase selectivity, anti-inflammatory and ulcerogenic liability. While compounds 13e, 13h and 13i showed moderate COX-2 selectivity in vitro and good anti-inflammatory activity in vivo, compound 13i showed the highest anti-inflammatory activity that is very close in potency to the reference drug (celecoxib) with better gastric profile than celecoxib.

引用

页码：1932 / 1942

页数：11

共 36 条

[1] Novel pyrazolopyrimidine derivatives targeting COXs and iNOS enzymes; design, synthesis and biological evaluation as potential anti-inflammatory agents [J].

Abdelazeem, Ahmed H. ;

Abdelatef, Shaimaa A. ;

El-Saadi, Mohammed T. ;

Omar, Hany A. ;

Khan, Shabana I. ;

McCurdy, Christopher R. ;

El-Moghazy, Samir M. .

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 62 :197-211

[2] Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-hydroxymethylphenyl)-1-(4-aminosulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its methanesulfonyl analog: Synthesis, biological evaluation and nitric oxide release studies [J].

Abdellatif, Khaled R. A. ;

Chowdhury, Morshed Alam ;

Dong, Ying ;

Velazquez, Carlos ;

Das, Dipankar ;

Suresh, Mavanur R. ;

Knaus, Edward E. .

BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (22) :9694-9698

[3] Diazen-1-ium-1,2-diolatednitric oxide donor ester prodrugs of 1-(4-methanesulfonylphenyl)-5-aryl-1H-pyrazol-3-carboxylic acids:: Synthesis, nitric oxide release studies and anti-inflammatory activities [J].

Abdellatif, Khaled R. A. ;

Chowdhury, Morshed Alam ;

Dong, Ying ;

Knaus, Edward E. .

BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (13) :6528-6534

[4] Celecoxib prodrugs possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Synthesis, biological evaluation and nitric oxide release studies [J].

Abdellatif, Khaled R. A. ;

Chowdhury, Morshed A. ;

Velazquez, Carlos A. ;

Huang, Zhangjian ;

Dong, Ying ;

Das, Dipankar ;

Yu, Gang ;

Suresh, Mavanur R. ;

Knaus, Edward E. .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (15) :4544-4549

[5] Synthesis of New 1-[4-Methane(amino)sulfonylphenyl)]-5-[4-(aminophenyl)]-3-trifluoromethyl-1H-pyrazoles [J].

Abdellatif, Khaled R. A. ;

Chowdhury, Morshed A. ;

Knaus, Edward E. .

JOURNAL OF HETEROCYCLIC CHEMISTRY, 2008, 45 (06) :1707-1710

[6] Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-carboxymethylphenyl)-1-(4-methanesulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its aminosulfonyl analog: Synthesis, biological evaluation and nitric oxide release studies [J].

Abdellatif, Khaled R. A. ;

Chowdhury, Morshed Alam ;

Dong, Ying ;

Das, Dipankar ;

Yu, Gang ;

Velazquez, Carlos ;

Suresh, Mavanur R. ;

Knaus, Edward E. .

BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (14) :5182-5188

[7] CYP2C9 structure-metabolism relationships:: Optimizing the metabolic stability of COX-2 inhibitors [J].

Ahlstroem, Marie M. ;

Ridderstroem, Marianne ;

Zamora, Ismael ;

Luthman, Kristina .

JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (18) :4444-4452

[8] Synthesis and DP-IV inhibition of cyano-pyrazoline derivatives as potent anti-diabetic agents [J].

Ahn, JH ;

Kim, HM ;

Jung, SH ;

Kang, SK ;

Kim, KR ;

Rhee, SD ;

Yang, SD ;

Cheon, HG ;

Kim, SS .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (17) :4461-4465

[9] Synthesis and evaluation of 1,5-diaryl-substituted tetrazoles as novel selective cyclooxygenase-2 (COX-2) inhibitors [J].

Al-Hourani, Baker Jawabrah ;

Sharma, Sai Kiran ;

Mane, Jonathan Y. ;

Tuszynski, Jack ;

Baracos, Vickie ;

Kniess, Torsten ;

Suresh, Mavanur ;

Pietzsch, Jens ;

Wuest, Frank .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (06) :1823-1826

[10] Synthesis and antimicrobial activities of new 4,6-diaryl-4,5-dihydro-3-hydroxy-2H-indazoles [J].

Amutha, Parasuraman ;

Nagarajan, Samuthira .

JOURNAL OF HETEROCYCLIC CHEMISTRY, 2012, 49 (02) :428-432

← 1 2 3 4 →